Terminated OBSERVATIONAL NCT05142540

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines (CoVVacBoost)

Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines - The CoVVacBoost Study

Sponsor: Medical University of Graz

Conditions Anti-SARS-CoV-2 Antibody Response

Interventions blood and saliva samples will be taken

Updated 4 times since 2022 Last updated: Jan 9, 2023 Started: Dec 1, 2021 Primary completion: Oct 4, 2022 Completion: Oct 4, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No more booster vaccinations are being carried out at the site. Further recruitment is therefore not possible.

Other terminated trials from Medical University of Graz

See all terminations from Medical University of Graz

This observational or N/A phase trial investigates Anti-SARS-CoV-2 Antibody Response and is currently terminated or withdrawn. Medical University of Graz leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Feb 2023 — Jul 2024 [monthly]

Terminated

Status: Recruiting → Terminated
Jan 2022 — Feb 2023 [monthly]

Recruiting

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Graz

Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Graz, Austria